Exploring Next-Generation ADCs: Future Insight for Dual Payload ADCs
- Showcasing traditional cytotoxic ADC development and combination of IO drug, headlined by the approval and success of Padcev
- Exploring next-generation ADCs delivering an immune agonist payload and their expansion toward next-generation immunostimulatory dual payload ADC
- Discussing a strategy for a next-generation ADC, challenges and solutions